ExCellThera Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $5.3M

  • Investors
  • 3

ExCellThera General Information

Description

Developer of a cell therapy platform designed to address blood cancers. The company offers UM171 Cell Therapy (dorocubicel) utilizing genetically engineered hematopoietic stem cells focused on delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, enabling patients with blood cancers to access a potentially transformative treatment with the aim of improving survival outcomes.

Contact Information

Website
www.excellthera.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 2950 Chemin de Polytechnique
  • Chemin de Polytechnique
  • Montreal, Quebec H3T 1J4
  • Canada
+1 (514)
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Life Sciences
Corporate Office
  • 2950 Chemin de Polytechnique
  • Chemin de Polytechnique
  • Montreal, Quebec H3T 1J4
  • Canada
+1 (514)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ExCellThera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 11-Apr-2025 $5.3M Completed Clinical Trials - Phase 3
2. Accelerator/Incubator Completed Clinical Trials - Phase 3
1. Grant 05-Apr-2017 $14.9K Completed Clinical Trials - Phase 3
To view ExCellThera’s complete valuation and funding history, request access »

ExCellThera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ExCellThera Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Government of Quebec Government
Centre for Commercialization of Regenerative Medicine Corporation
University of Toronto Entrepreneurship Accelerator/Incubator
To view ExCellThera’s complete investors history, request access »

Ready to get started?

Request a free trial

ExCellThera FAQs

  • When was ExCellThera founded?

    ExCellThera was founded in 2014.

  • Where is ExCellThera headquartered?

    ExCellThera is headquartered in Montreal, Canada.

  • What is the size of ExCellThera?

    ExCellThera has 19 total employees.

  • What industry is ExCellThera in?

    ExCellThera’s primary industry is Biotechnology.

  • Is ExCellThera a private or public company?

    ExCellThera is a Private company.

  • What is ExCellThera’s current revenue?

    The current revenue for ExCellThera is .

  • Who are ExCellThera’s investors?

    Government of Quebec, Centre for Commercialization of Regenerative Medicine, and University of Toronto Entrepreneurship have invested in ExCellThera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »